206 related articles for article (PubMed ID: 3977279)
41. Risk factors and antiemetic management of chemotherapy-induced nausea and vomiting.
Goodman M
Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):20-32. PubMed ID: 9282378
[TBL] [Abstract][Full Text] [Related]
42. Antiemetics for cancer chemotherapy-induced nausea and vomiting. Summary and table.
Palmer KJ; Poole R
Drugs R D; 1999 Oct; 2(4):237-9. PubMed ID: 10659397
[No Abstract] [Full Text] [Related]
43. Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study.
Booth CM; Clemons M; Dranitsaris G; Joy A; Young S; Callaghan W; Trudeau M; Petrella T
J Support Oncol; 2007 Sep; 5(8):374-80. PubMed ID: 17944146
[TBL] [Abstract][Full Text] [Related]
44. Prevention of chemotherapy-induced nausea and vomiting in patients with cancer.
Aapro MS
Ariz Med; 1981 Nov; 38(11):843-5. PubMed ID: 6274276
[No Abstract] [Full Text] [Related]
45. NCCN antiemesis guidelines emphasize 'delayed' emesis, new 5-HT3 inhibitors, and NK-1 blockers.
National Comprehensive Cancer Network (NCCN)
J Support Oncol; 2004; 2(4):366. PubMed ID: 15357520
[No Abstract] [Full Text] [Related]
46. [Antiblastic agent-induced vomiting: possibilities of its prevention and alizapride therapy].
Petrella V; Cantone PA; Alciato P; Gagliardini R; Fico D
Minerva Med; 1989 Apr; 80(4):389-92. PubMed ID: 2725942
[TBL] [Abstract][Full Text] [Related]
47. Nabilone and high-dose metoclopramide: anti-emetics for cancer chemotherapy.
Drug Ther Bull; 1984 Feb; 22(3):9-11. PubMed ID: 6321126
[No Abstract] [Full Text] [Related]
48. [Chemotherapy induced-vomiting--a practical guide for prevention and therapy].
Jordan K; Voigt W; Schmoll HJ
Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1869-72. PubMed ID: 16915549
[TBL] [Abstract][Full Text] [Related]
49. [Croatian guideliness for prevention of chemotherapy induced nausea and vomiting].
Tomek R; Vrdoljak E; Vrbanec D; Nemet D; Matković V; Plestina S; Gugić D; Dintinjana RD; Bolanca A; Samarzija M; Petković M
Lijec Vjesn; 2009; 131(3-4):49-53. PubMed ID: 19514248
[TBL] [Abstract][Full Text] [Related]
50. Prevention of emesis by tropisetron (Navoban) in children receiving cytotoxic therapy for solid malignancies.
Otten J; Hachimi-Idrissi S; Balduck N; Maurus R
Semin Oncol; 1994 Oct; 21(5 Suppl 9):17-9. PubMed ID: 9113122
[TBL] [Abstract][Full Text] [Related]
51. Nausea and vomiting induced by chemotherapeutic agents.
Grunberg S
Compr Ther; 1991 Dec; 17(12):39-43. PubMed ID: 1790665
[No Abstract] [Full Text] [Related]
52. Palonosetron (Aloxi) for prevention of nausea and vomiting due to cancer chemotherapy.
Med Lett Drugs Ther; 2004 Mar; 46(1179):27-8. PubMed ID: 15057189
[No Abstract] [Full Text] [Related]
53. [Clinical evaluation of 2 mg granisetron tablet for nausea and vomiting induced by anticancer drugs including cisplatin].
Takada M; Furuse K; Fukuoka M; Kawahara M; Negoro S; Kusunoki Y; Ogawara M; Furue H
Gan To Kagaku Ryoho; 1997 Jun; 24(8):987-94. PubMed ID: 9212809
[TBL] [Abstract][Full Text] [Related]
54. Aprepitant: a neurokinin-1 receptor antagonist for the treatment of chemotherapy-induced nausea and vomiting.
Navari RM
Expert Rev Anticancer Ther; 2004 Oct; 4(5):715-24. PubMed ID: 15485308
[TBL] [Abstract][Full Text] [Related]
55. Chemotherapy-induced nausea and vomiting with special emphasis on metopimazine.
Herrstedt J
Dan Med Bull; 1998 Sep; 45(4):412-22. PubMed ID: 9777292
[No Abstract] [Full Text] [Related]
56. Rolapitant approved for chemotherapy-induced nausea and vomiting.
Traynor K
Am J Health Syst Pharm; 2015 Nov; 72(21):1838. PubMed ID: 26490812
[No Abstract] [Full Text] [Related]
57. [Clinical nursing care. Nausea and vomiting].
Vinsløv K; Vinggård R; Kopp K
Sygeplejersken; 1991 Sep; 91(36):10-3. PubMed ID: 1796371
[No Abstract] [Full Text] [Related]
58. [Clinical evaluation of 2-mg granisetron tablet for nausea and vomiting induced by anticancer drugs including cisplatin].
Yoshiya N; Kodama S; Aoki Y; Takahashi T; Honma S; Endo M; Tokunaga A; Takeuchi Y; Hanaoka J; Maruhashi T; Oshima T; Tanaka K; Furue H
Gan To Kagaku Ryoho; 1997 Jul; 24(9):1141-7. PubMed ID: 9239168
[TBL] [Abstract][Full Text] [Related]
59. Mechanism and treatment of nausea and vomiting.
Nagendran T; Nagendran S
Ala Med; 1990 Nov; 60(5):12-6. PubMed ID: 2291448
[No Abstract] [Full Text] [Related]
60. [Prochlorperazine Spofa in the therapy and prevention of nausea and vomiting following cytostatics].
Klener P
Cas Lek Cesk; 1979 Apr; 118(14):436-8. PubMed ID: 455360
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
